Status:

RECRUITING

Biomarkers in Immunotherapy of Melanoma

Lead Sponsor:

Institute of Oncology Ljubljana

Collaborating Sponsors:

Blood Transfusion Centre of Slovenia

University Medical Centre Ljubljana

Conditions:

Metastatic Melanoma

Immune Checkpoints Inhibitors

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Background: Immunotherapy has been successful in treating advanced melanoma, but a large proportion of patients do not respond to the treatment with immune checkpoint inhibitors (ICIs). Preclinical an...

Detailed Description

The goal of this \[type of study: observational study or clinical trial\] is to \[learn about, test, compare etc.\] in \[describe participant population/health conditions\]. The main question\[s\] it ...

Eligibility Criteria

Inclusion Criteria:

  • Age over 18 years
  • Cytologically or histologically verified malignant melanoma
  • Stage IIID unresectable/IV according to AJCC classification (8th edition, 2018)
  • Performance status according to WHO 0 - 2 (ECOG criteria)
  • 1st line of systemic treatment with immunotherapy (nivolumab, ipi/nivo, pembrolizumab)
  • Triple CT/PET CT done within 4 weeks before the first application
  • Signed consent to participate in clinical research

Exclusion Criteria:

  • Previously treated melanoma with systemic therapy
  • Capacity status according to WHO 3 - 4 (ECOG criteria)
  • Contraindications for immunotherapy treatment (known deficiency of the immune system or active immunosuppressive treatment or active autoimmune disease requiring treatment)
  • Other malignant diseases (except cured basal cell carcinoma and squamous cell carcinoma)

Key Trial Info

Start Date :

October 5 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2027

Estimated Enrollment :

150 Patients enrolled

Trial Details

Trial ID

NCT05878977

Start Date

October 5 2022

End Date

December 31 2027

Last Update

October 18 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Institute of Oncology Ljubljana

Ljubljana, Slovenia